By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


INNOVIVE Pharmaceuticals 

555 Madison Avenue
25th Floor
New York  New York  10022  U.S.A.
Phone: 212-716-1810 Fax: 212-716-1811


Company News
CytRx Corporation (CYTR) Completes Acquisition of INNOVIVE Pharmaceuticals 9/22/2008 9:05:15 AM
CytRx Corporation (CYTR) Signs Definitive Agreement to Acquire INNOVIVE Pharmaceuticals 6/9/2008 6:27:01 AM
INNOVIVE Pharmaceuticals Presents Phase I Data on INNO-406 for Treatment of Gleevec-Resistant or Intolerant Chronic Myelogenous Leukemia at American Society of Hematology 12/10/2007 11:35:43 AM
INNOVIVE Pharmaceuticals Presents Preliminary Data at American Society of Hematology Showing INNO-305 Elicits Immune Response in Patients with Myeloid and Thoracic Neoplasms 12/9/2007 11:55:41 PM
Data from INNOVIVE Pharmaceuticals' Oncology Drug Programs to be Presented at the American Society of Hematology 49th Annual Meeting 12/5/2007 12:06:52 PM
INNOVIVE Pharmaceuticals Initiates Pivotal Phase II Clinical Trial with Tamibarotene 11/15/2007 9:07:35 AM
INNOVIVE Pharmaceuticals to Present at the Paramount BioSciences Annual Healthcare Conference 10/19/2007 12:45:23 PM
INNOVIVE Pharmaceuticals Announces Receipt of FDA Orphan Drug Designation for Tamibarotene for the Treatment of Acute Promyelocytic Leukemia 10/15/2007 11:28:16 AM
INNOVIVE Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 9/11/2007 11:48:51 AM
INNOVIVE Pharmaceuticals Acquires Exclusive Rights to Develop and Commercialize Tamibarotene in Europe 9/10/2007 11:49:51 AM